Opus Genetics, Stock Price on November 24, 2024
| IRD Stock | 1.05 0.04 3.67% |
Below is the normalized historical share price chart for Opus Genetics, extending back to November 30, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Opus Genetics, stands at 1.05, as last reported on the 28th of November, with the highest price reaching 1.09 and the lowest price hitting 1.03 during the day.
If you're considering investing in Opus Stock, it is important to understand the factors that can impact its price. Opus Genetics, maintains Sharpe Ratio (i.e., Efficiency) of -0.0319, which implies the firm had a -0.0319% return per unit of risk over the last 3 months. Opus Genetics, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Opus Genetics,'s Variance of 21.75, coefficient of variation of (3,876), and Risk Adjusted Performance of (0.01) to confirm the risk estimate we provide.
The current year's Issuance Of Capital Stock is expected to grow to about 12.7 M, whereas Total Stockholder Equity is forecasted to decline to about 28.8 M. . Opus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 2005 |
Opus |
Sharpe Ratio = -0.0319
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IRD |
Estimated Market Risk
| 4.71 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Opus Genetics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Opus Genetics, by adding Opus Genetics, to a well-diversified portfolio.
Related Headline
Viracta Therapeutics Headline on 22nd of November 2024
Acquisition by Lisa Rojkjaer of 4127 shares of Viracta Thera... by Lisa Rojkjaer
Filed transaction by Viracta Therapeutics Officer Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Opus Genetics, Valuation on November 24, 2024
It is possible to determine the worth of Opus Genetics, on a given historical date. On November 24, 2024 Opus was worth 0.99 at the beginning of the trading date compared to the closed value of 1.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Opus Genetics, stock. Still, in general, we apply an absolute valuation method to find Opus Genetics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Opus Genetics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Opus Genetics,'s related companies.
| Open | High | Low | Close | Volume | |
| 0.98 | 1.00 | 0.97 | 0.98 | 83,128 | |
11/22/2024 | 0.99 | 1.01 | 0.98 | 1.01 | 289,798 |
| 1.08 | 1.12 | 1.02 | 1.10 | 218,915 |
| Backtest Opus Genetics, | | | Opus Genetics, History | | | Opus Genetics, Valuation | Previous | Next |
Opus Genetics, Trading Date Momentum on November 24, 2024
| On November 25 2024 Opus Genetics, was traded for 1.10 at the closing time. Highest Opus Genetics,'s price during the trading hours was 1.12 and the lowest price during the day was 1.02 . The net volume was 218.9 K. The overall trading history on the 25th of November contributed to the next trading period price growth. The trading delta at closing time to the next next day price was 8.91% . The trading delta at closing time to current price is 6.93% . |
Opus Genetics, Fundamentals Correlations and Trends
By evaluating Opus Genetics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Opus Genetics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Opus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Opus Genetics, Stock history
Opus Genetics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Opus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Opus Genetics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Opus Genetics, stock prices may prove useful in developing a viable investing in Opus Genetics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24 M | 20.5 M |
Opus Genetics, Quarterly Net Working Capital |
|
Opus Genetics, Stock Technical Analysis
Opus Genetics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Opus Genetics, Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Opus Genetics, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Opus Genetics, November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Opus Genetics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Opus Genetics, shares will generate the highest return on investment. By undertsting and applying Opus Genetics, stock market strength indicators, traders can identify Opus Genetics, entry and exit signals to maximize returns
Opus Genetics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Opus Genetics,'s price direction in advance. Along with the technical and fundamental analysis of Opus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Opus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Opus Stock analysis
When running Opus Genetics,'s price analysis, check to measure Opus Genetics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics, is operating at the current time. Most of Opus Genetics,'s value examination focuses on studying past and present price action to predict the probability of Opus Genetics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics,'s price. Additionally, you may evaluate how the addition of Opus Genetics, to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |